<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01319500</url>
  </required_header>
  <id_info>
    <org_study_id>ZEG 2009_02</org_study_id>
    <nct_id>NCT01319500</nct_id>
  </id_info>
  <brief_title>Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia</brief_title>
  <official_title>Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Epidemiology and Health Research, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Center for Epidemiology and Health Research, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the drug utilization pattern of Oral Contraceptives (OC) in Croatia.
      Gynecologists and Dermatologists were asked to contribute OC prescribing data to this study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Large, prospective non-interventional cohort studies with active surveillance of study
      participants indicate that many users of oral contraceptives use these preparations not only
      for contraception but also for the treatment of hormone-dependent diseases and symptoms -
      such as premenstrual dysphoric disorder, acne, endometriosis, ovarian cysts, polycystic ovary
      syndrome, bleeding disorders and painful periods. In the International Active Surveillance
      Study of Women Taking Oral Contraceptives (INAS) more than 30% of participants reported that
      they use their OC for contra¬ception as well as for the treatment of one of the mentioned
      conditions.

      It is also conceivable that some women use OC not for contraception but only for one of these
      hormone-dependent conditions. In most instances the exclusive use for these conditions would
      constitute off-label use as only few preparations have a stand-alone approved indication for
      one of these conditions.

      For many countries the actual extent of off-label use of OCs for these conditions is unknown.
      This applies also to Croatia. Therefore, the Croatian health authority requested a drug
      utilization study to investigate current prescribing indications for Yasmin® and other OCs in
      Croatia. The study details were agreed upon with the Croatian health authority.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>OC Prescriptions by Treatment Group and Prescribing Medical Specialists</measure>
    <time_frame>February 2009 - March 2009</time_frame>
    <description>Prescriptions of Yasmin and Other OCs by different physicians (private gynecologists, public gynecologists and dermatologists)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reasons for OC Prescriptions</measure>
    <time_frame>February 2009 - March 2009</time_frame>
    <description>The main reasons for OC prescription: contraception only; contraception combined with non-contraceptive reasons; non-contraceptive reasons only.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for &quot;Contraceptive and Non-contraceptive&quot; and &quot;Non-contraceptive Only&quot; Reasons</measure>
    <time_frame>February 2009 - March 2009</time_frame>
    <description>Non-contraceptive reasons for OC prescriptions (including both categories: &quot;contraception plus non-contraceptive reasons&quot; and &quot;non-contraceptive reasons only&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for Non-contraceptive Reasons Only)</measure>
    <time_frame>February 2009 - March 2009</time_frame>
    <description>Exclusively non-contraceptive reasons for OC prescriptions (no contraception intended; category &quot;non-contraceptive reasons only&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reasons for OC Prescriptions by Gynecologists and Dermatologists</measure>
    <time_frame>February 2009 - March 2009</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">3776</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Yasmin</arm_group_label>
    <description>Users of the drospirenone/ethinylestradiol (DRSP/EE) containing OC &quot;Yasmin&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other OCs</arm_group_label>
    <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Overall, a representative sample of 100 gynecologists and 31 dermatologists are asked to
        contribute OC prescribing data to this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with an OC prescription during the timeframe (Feb-March 2011)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juergen C Dinger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berlin Center for Epidemiology and Health Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Epidemiology and Health Research Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2011</study_first_submitted>
  <study_first_submitted_qc>March 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2011</study_first_posted>
  <results_first_submitted>August 15, 2012</results_first_submitted>
  <results_first_submitted_qc>October 17, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 20, 2012</results_first_posted>
  <last_update_submitted>October 17, 2012</last_update_submitted>
  <last_update_submitted_qc>October 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Center for Epidemiology and Health Research, Germany</investigator_affiliation>
    <investigator_full_name>Juergen Dinger, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Drug Utilization</keyword>
  <keyword>Oral Contraceptives</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drospirenone and ethinyl estradiol combination</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A representative sample of 100 Croatian gynecologists and 31 dermatologists were asked to fill in a questionnaire for each of their oral contraceptive (OC) prescriptions from February 16, 2009 to March 15, 2009. Questions included the name of the OC, date and reason for prescription, and the reproductive status and demographics of the patients.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Yasmin</title>
          <description>Users of the drospirenone/ethinylestradiol (DRSP/EE) containing OC &quot;Yasmin&quot;</description>
        </group>
        <group group_id="P2">
          <title>Other OCs</title>
          <description>Users of oral contraceptives (OCs) except Yasmin (&quot;Other OCs&quot;)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1187"/>
                <participants group_id="P2" count="2589"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1187"/>
                <participants group_id="P2" count="2589"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Yasmin</title>
          <description>Users of the DRSP/EE containing OC &quot;Yasmin&quot;</description>
        </group>
        <group group_id="B2">
          <title>Other OCs</title>
          <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1187"/>
            <count group_id="B2" value="2589"/>
            <count group_id="B3" value="3776"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.8" spread="5.0"/>
                    <measurement group_id="B2" value="26.5" spread="6.3"/>
                    <measurement group_id="B3" value="25.7" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=18 and &lt;40 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1097"/>
                    <measurement group_id="B2" value="2398"/>
                    <measurement group_id="B3" value="3495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=40 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1187"/>
                    <measurement group_id="B2" value="2589"/>
                    <measurement group_id="B3" value="3776"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Croatia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1187"/>
                    <measurement group_id="B2" value="2589"/>
                    <measurement group_id="B3" value="3776"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>OC Prescriptions by Treatment Group and Prescribing Medical Specialists</title>
        <description>Prescriptions of Yasmin and Other OCs by different physicians (private gynecologists, public gynecologists and dermatologists)</description>
        <time_frame>February 2009 - March 2009</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Yasmin</title>
            <description>Users of the DRSP/EE containing OC &quot;Yasmin&quot;</description>
          </group>
          <group group_id="O2">
            <title>Other OCs</title>
            <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
          </group>
        </group_list>
        <measure>
          <title>OC Prescriptions by Treatment Group and Prescribing Medical Specialists</title>
          <description>Prescriptions of Yasmin and Other OCs by different physicians (private gynecologists, public gynecologists and dermatologists)</description>
          <units>Prescribing physicians</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1187"/>
                <count group_id="O2" value="2589"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Gynecologists (private practice)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="244"/>
                    <measurement group_id="O2" value="331"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gynecologists (public practice)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="929"/>
                    <measurement group_id="O2" value="2213"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatologists</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Reasons for OC Prescriptions</title>
        <description>The main reasons for OC prescription: contraception only; contraception combined with non-contraceptive reasons; non-contraceptive reasons only.</description>
        <time_frame>February 2009 - March 2009</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Yasmin</title>
            <description>Users of the DRSP/EE containing OC &quot;Yasmin&quot;</description>
          </group>
          <group group_id="O2">
            <title>Other OCs</title>
            <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
          </group>
        </group_list>
        <measure>
          <title>Reasons for OC Prescriptions</title>
          <description>The main reasons for OC prescription: contraception only; contraception combined with non-contraceptive reasons; non-contraceptive reasons only.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1187"/>
                <count group_id="O2" value="2589"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Contraception only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.8" lower_limit="51.0" upper_limit="56.7"/>
                    <measurement group_id="O2" value="57.8" lower_limit="55.9" upper_limit="59.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Contraception plus non-contraceptive reasons</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.8" lower_limit="36.0" upper_limit="41.6"/>
                    <measurement group_id="O2" value="29.7" lower_limit="27.9" upper_limit="31.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-contraceptive reasons only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" lower_limit="4.0" upper_limit="6.7"/>
                    <measurement group_id="O2" value="11.6" lower_limit="10.4" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for &quot;Contraceptive and Non-contraceptive&quot; and &quot;Non-contraceptive Only&quot; Reasons</title>
        <description>Non-contraceptive reasons for OC prescriptions (including both categories: &quot;contraception plus non-contraceptive reasons&quot; and &quot;non-contraceptive reasons only&quot;</description>
        <time_frame>February 2009 - March 2009</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Yasmin</title>
            <description>Users of the DRSP/EE containing OC &quot;Yasmin&quot;</description>
          </group>
          <group group_id="O2">
            <title>Other OCs</title>
            <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
          </group>
        </group_list>
        <measure>
          <title>Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for &quot;Contraceptive and Non-contraceptive&quot; and &quot;Non-contraceptive Only&quot; Reasons</title>
          <description>Non-contraceptive reasons for OC prescriptions (including both categories: &quot;contraception plus non-contraceptive reasons&quot; and &quot;non-contraceptive reasons only&quot;</description>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="522"/>
                <count group_id="O2" value="1068"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Acne</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="226"/>
                    <measurement group_id="O2" value="338"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Painful period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="212"/>
                    <measurement group_id="O2" value="246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="199"/>
                    <measurement group_id="O2" value="405"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal menstrual bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="254"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bleeding on demand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ovarian cysts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uterine disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMDD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperandrogenism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for Non-contraceptive Reasons Only)</title>
        <description>Exclusively non-contraceptive reasons for OC prescriptions (no contraception intended; category &quot;non-contraceptive reasons only&quot;</description>
        <time_frame>February 2009 - March 2009</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Yasmin</title>
            <description>Users of the DRSP/EE containing OC &quot;Yasmin&quot;</description>
          </group>
          <group group_id="O2">
            <title>Other OCs</title>
            <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
          </group>
        </group_list>
        <measure>
          <title>Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for Non-contraceptive Reasons Only)</title>
          <description>Exclusively non-contraceptive reasons for OC prescriptions (no contraception intended; category &quot;non-contraceptive reasons only&quot;</description>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="300"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PCOS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acne</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Painful period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal menstrual bleeding</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bleeding on demand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ovarian cysts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uterine disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMDD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperandrogenism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Reasons for OC Prescriptions by Gynecologists and Dermatologists</title>
        <time_frame>February 2009 - March 2009</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gynecologists (All)</title>
            <description>All gynecologists (private and public)</description>
          </group>
          <group group_id="O2">
            <title>Gynecologists (Private Practice Only)</title>
            <description>Gynecologists in private practice only</description>
          </group>
          <group group_id="O3">
            <title>Gynecologists (Public Practice Only)</title>
            <description>Gynecologists in public practice only</description>
          </group>
          <group group_id="O4">
            <title>Dermatologists</title>
            <description>All dermatologists</description>
          </group>
          <group group_id="O5">
            <title>Total</title>
            <description>All gynecologists (private and public) and dermatologists</description>
          </group>
        </group_list>
        <measure>
          <title>Reasons for OC Prescriptions by Gynecologists and Dermatologists</title>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3717"/>
                <count group_id="O2" value="575"/>
                <count group_id="O3" value="3142"/>
                <count group_id="O4" value="59"/>
                <count group_id="O5" value="3776"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Contraception only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2130"/>
                    <measurement group_id="O2" value="347"/>
                    <measurement group_id="O3" value="1783"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="2135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Contraceptive plus non-contraceptive reasons</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1201"/>
                    <measurement group_id="O2" value="178"/>
                    <measurement group_id="O3" value="1023"/>
                    <measurement group_id="O4" value="27"/>
                    <measurement group_id="O5" value="1228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-contraceptive reasons only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="337"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="305"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="362"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse event data were not collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>Yasmin</title>
          <description>Users of the DRSP/EE containing OC &quot;Yasmin&quot;</description>
        </group>
        <group group_id="E2">
          <title>Other OCs</title>
          <description>Users of OCs except Yasmin (&quot;Other OCs&quot;)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Juergen Dinger</name_or_title>
      <organization>Center for Epidemiology and Health Research Berlin</organization>
      <phone>+49 (0)30 945 10145</phone>
      <email>dinger@zeg-berlin.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

